Pelvic Organ Prolapse

Different surgical approaches to apical pelvic organ prolapse were significantly associated with different long-term risks for reoperation among women aged 65 years or older, according to study results published in Obstetrics & Gynecology.

Two experts recently debated the value of low-carb diets in gestational diabetes at the American Diabetes Association Scientific Sessions.

Pessaries customized through transvaginal ultrasound and 3D printing technology may perform better if commercial pessaries fail for women with pelvic organ prolapse, according to results of a pilot study published in Menopause.

A Michigan statewide analysis found significant variations in surgical approaches for hysterectomies performed to treat pelvic organ prolapse, according to study data.

Patient-reported improvement of pelvic organ prolapse symptoms was similar for pessary vs. surgery, but ultimately did not meet the noninferiority endpoint in a 2-year randomized clinical trial, according to data published in JAMA.

Among women with a previous cesarean section, those who underwent vaginal delivery instead of another cesarean delivery were more likely to need pelvic floor surgery, according to data published in PLOS Medicine.

Women who underwent cesarean delivery may have lower chances of pelvic organ prolapse and stress urinary incontinence surgeries, according to a register-based linkage study published in the American Journal of Obstetrics & Gynecology.

Compared with pessary therapy, women who underwent surgery for symptomatic pelvic organ prolapse reported greater subjective improvement and sexual well-being, according to 1-year interim results of a randomized controlled trial.

Transvaginal mesh was noninferior to native tissue repair in women with pelvic organ prolapse at 36 months, according to a prospective, nonrandomized study published in Obstetrics & Gynecology.

Women with higher BMI, greater anatomical failure and smoking had a greater recurrence of pelvic organ prolapse — or POP — within 5 years of surgery, according to a secondary analysis of the SAVE-U trial.